FDA panel votes against approving Intellipharma's opioid painkiller – Reuters


FDA panel votes against approving Intellipharma’s opioid painkiller
(Reuters) – A panel of independent advisers to the U.S. Food and Drug Administration overwhelmingly concluded on Wednesday that there is not enough evidence to support approval of Intellipharmaceutics International Inc’s long-acting opioid painkiller.
FDA panel votes against ‘abuse-deterrent’ opioid with blue dyeABC News
FDA Committee Votes Down Approval Of Abuse-Deterrent OpioidInside Health Policy (subscription)

all 6 news articles »

View original article

Powered by WPeMatico